Public awareness and knowledge of herpes zoster: Results of a global survey

Gerontology

Volumn 56, Issue 1, 2010, Pages 20-31

  Paek, Esther ^a   Johnson, Robert ^a  

^a NONE

Author keywords

Herpes zoster, survey; Neuralgia, postherpetic; Shingles

Indexed keywords

ANALGESIC AGENT; ANTIVIRUS AGENT; CORTICOSTEROID; HOMEOPATHIC AGENT;

ADULT; ALLOPATHY; ALTERNATIVE MEDICINE; ARTICLE; AWARENESS; BLISTER; CHICKENPOX; CHINESE MEDICINE; FATIGUE; FEMALE; FEVER; GEOGRAPHIC DISTRIBUTION; GROUPS BY AGE; HEALTH SURVEY; HERPES ZOSTER; HUMAN; INFECTION RISK; KNOWLEDGE; MALE; MEDICAL SPECIALIST; MORBIDITY; PRIORITY JOURNAL; QUALITY OF LIFE; RASH; SKIN PRURITUS; WEAKNESS;

FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SURVEYS; HERPES ZOSTER; HUMANS; MALE; MIDDLE AGED; PUBLIC OPINION; WORLD HEALTH;

EID: 76449110615     PISSN: 0304324X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000240046     Document Type: Article

References (20)

1. Wareham DW, Breuer J: Herpes zoster. BMJ 2007; 334: 1211-1215.
2. Shingles (Herpes Zoster) Statistics: Global Information Hub for Integrated Medicine web site. http://content.nhiondemand.com/ moh/media/HC2asp?objID=100635&cType= hc. Accessed April 4, 2007.
3. Kimberlin DW, Whitley RJ: Varicella-zoster vaccine for the prevention of herpes zoster. N Engl J Med 2007; 356: 1338-1343.
4. Chidiac C, Bruxelle J, Daures JP, Hoang-Xuan T, Morel P, Leplege A, El Hasnaoui A, de Labareyre C: Characteristics of patients with herpes zoster on presentation to practitioners in France. Clin Infect Dis 2001; 33: 62-69.
5. Opstelten W, Mauritz JW, de Wit NJ, van Wijck AJ, Stalman WA, van Essen GA: Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database. Fam Pract 2002; 19: 471-475.
6. di Luzio PU, Arpinelli F, Visona G: Herpes zoster and its complications in Italy: an observational survey. J Infect 1999; 38: 116-120.
7. Arvin A: Aging, immunity, and the varicella-zoster virus. N Engl J Med 2005; 352: 2266-2267.
8. Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ: Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 2000; 342: 635-645.
9. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, Weinberg A, Boardman KD, Williams HM, Zhang JH, Peduzzi PN, Beisel CE, Morrison VA, Guatelli JC, Brooks PA, Kauffman CA, Pachucki CT, Neuzil KM, Betts RF, Wright PF, Griffin MR, Brunell P, Soto NE, Marques AR, Keay SK, Goodman RP, Cotton DJ, Gnann JW Jr, Loutit J, Holodniy M, Keitel WA, Crawford GE, Yeh SS, Lobo Z, Toney JF, Greenberg RN, Keller PM, Harbecke R, Hayward AR, Irwin MR, Kyriakides TC, Chan CY, Chan IS, Wang WW, Annunziato PW, Silber JL: A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352: 2271-2284.
10. Dworkin RH, White R, O'Connor AB, Baser O, Hawkins K: Healthcare costs of acute and chronic pain associated with a diagnosis of herpes zoster. J Am Geriatr Soc 2007; 55: 1168-1175.
11. Gauthier A, Breuer J, Carrington D, Martin M, Remy V: Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom. Epidemiol Infect 2009; 137: 38-47.
12. Scott FT, Johnson RW, Leedham-Green M, Davies E, Edmunds WJ, Breuer J: The burden of herpes zoster: a prospective population based study. Vaccine 2006; 24: 1308-1314.
13. Dworkin RH, Johnson RW, Breuer J, Gnann JW, Levin MJ, Backonja M, Betts RF, Gershon AA, Haanpaa ML, McKendrick MW, Nurmikko TJ, Oaklander AL, Oxman MN, Pavan-Langston D, Petersen KL, Rowbotham MC, Schmader KE, Stacey BR, Tyring SK, van Wijck AJ, Wallace MS, Wassilew SW, Whitley RJ: Recommendations for the management of herpes zoster. Clin Infect Dis 2007; 44(suppl 1):S1-S26.
14. Volpi A, Gross G, Hercogova J, Johnson RW: Current management of herpes zoster: the European view. Am J Clin Dermatol 2005; 6: 317-325.
15. Burke MS: Herpes zoster vaccine: clinical trial evidence and implications for medical practice. J Am Osteopath Assoc 2007; 107: S14-S18.
16. Holcomb K, Weinberg JM: A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia. J Drugs Dermatol 2006; 5: 863-866.
17. Wood MJ, Johnson RW, McKendrick MW, Taylor J, Mandal BK, Crooks J: A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med 1994; 330: 896-900.
18. Whitley RJ, Weiss H, Gnann J: The efficacy of steroids and acyclovir therapy of herpes zoster in the elderly. Antiviral Res 1995; 26: A303.
19. Johnson RW: Patient awareness of herpes zoster: the Global Herpes Zoster Survey - a preliminary report. Herpes 2006; 13(suppl 1):40A-41A.
20. Alfonso M, Richter-Appelt H, Tosti A, Viera MS, Garcia M: The psychosocial impact of hair loss among men: a multinational European study. Curr Med Res Opin 2005; 21: 1829-1836.